Streamlined, automation-ready approaches help scientists reproducibly generate antibody data with high-yield HEK293 transient ...

The HEK293 cell line was initially produced in 1973 by a team led by Alex van der Eb in Leiden (Netherlands) from normal fetal human embryonic kidney cells. These cells were created following ...

Every scientist wants to make an impact, though very few are able to identify a single experiment of theirs which led to the establishment of an entire scientific field. In early 1973, Frank Graham ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...

Biotherapeutics are transforming healthcare for over 350 million patients globally, tackling everything from cancer and diabetes to rare diseases. Human embryonic kidney (HEK) 293 cells play a key ...

Cell culture media specialized for gene therapy production are uniquely designed to support the growth, viability, and productivity of cells used to manufacture gene therapy products, such as viral ...

HEK293 cells are widely used in cell and gene therapy manufacturing. However, residual DNA contamination from HEK293 cells can have serious repercussions for patients and biopharmaceutical ...